Epigenetics in heart failure: mechanism and therapeutic targeting
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
Dr Watson’s research programme at QUB is primarily focused on investigating the impact that cardiovascular risk factors such as diabetes, hypertension, and inflammation have on cardiovascular remodelling, cardiac fibrosis, and heart failure.
This research is very translational and spans mechanistic work (fibrosis, hypertrophy, and epigenetics) right through to biomarker discovery programmes, clinical trials, and health services research. These research activities also span into low and middle income countries, particularly sub-Saharan Africa, through a Global Health (gHealth) Research consortium that Dr Watson has developed.
- Dr Chris Watson: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- askmhls@qub.ac.uk
- +44 (0)28 9097 6478
Research Interests
Open to PhD applications in the field of
Make a PhD enquiry
- Heart failure, Cardiomyopathy, Cardiac remodelling
- Diabetes, Hypertension, Ischaemia
- Biomarkers, Epigenetics, Fibrosis
- Global Health, mHealth
Current Research Opportunities
- Epigenetics in heart failure: mechanism and therapeutic targeting
Public outreach & key achievements
- International Director of Mzuzu-gHealth Clinical Research & Education Centre, Malawi
- Director and co-founder, QUB spin-out company: miCARE Technologies Ltd. [My Integrated CARE for real-time, remote monitoring and biomarker risk-stratification for chronic diseases].
- UCD 2016 Start-Up of the Year Award, co-founder, EpiCor Therapeutics - new drug for heart disease
- Pioneering research into heart failure
- New blood test could detect heart disease
Research students
PhD Title | Heart failure prevention: Investigating the use of known and novel biomarkers in heart failure prediction, disease stratification and monitoring response to therapeutic interventions
Country | Northern Ireland
PhD Title | The role of pathological structural changes in cardiovascular outcomes of patients undergoing cardiac biopsy or cancer therapies
Country | USA
PhD Title | Discovery of novel small RNAs from RNA-Seq Data
Country | Scotland
Alumni: Where are they now
PhD Title | Assessing the therapeutic potential of DNA methylation inhibitors for the treatment of pulmonary and cardiac fibrosis and remodelling
Country | Ireland
Current Position | Corporate Affairs Executive at Royal College of Physicians of Ireland
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Sciences
- Wellcome-Wolfson Institute For Experimental Medicine
- Institute for Health Sciences